Riverwater Partners LLC Abb Vie Inc. Transaction History

Riverwater Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 04, 2024	SELL	$137.6 - $154.97 $59,856 - $67,411	-435 Reduced 20.24%	1,714 $265,000
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $63,856 - $73,922	478 Added 28.61%	2,149 $320,000
Q1 2023 Apr 12, 2023	SELL	$144.61 - $166.54 $52,782 - $60,787	-365 Reduced 17.93%	1,671 $266,000
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $414 - $497	-3 Reduced 0.15%	2,036 $0
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $9,260 - $10,621	-69 Reduced 3.27%	2,039 $274,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $290,102 - $368,815	2,108 New	2,108 $323,000
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $353,838 - $439,013	-2,681 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $288,019 - $364,428	2,681 New	2,681 $363,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Riverwater Partners LLC with notifications on news.